Company Overview of Battelle Memorial Institute, Inc.
Battelle Memorial Institute, Inc. operates as a science and technology company that develops and commercializes technology in the United States. The company develops technology in the areas of energy, health and life sciences, national security and defense, laboratory management, and community and education. It also offers solutions for advanced materials, agrifood, consumer products, economic development, environment, industrial products, medical devices, pharmaceutical and biotechnology, public health, and transportation sectors, as well as manages laboratories for customers. In addition, the company conducts independent safety audits and assessments of train control/signaling systems and ...
505 King Avenue
Columbus, OH 43201-2696
Founded in 1923
Key Executives for Battelle Memorial Institute, Inc.
Chief Executive Officer and President
Chief Financial Officer and Executive Vice President
Senior Vice President of International Partnerships, Chief Executive Officer of Japan Office, Chief Executive Officer of Korea Office, President of Japan Office and President of Korea Office
Senior Vice President of Laboratory Operations and President of Battelle Energy Technology
President of National Security Global Business and General Manager of Battelles National Security Division
Compensation as of Fiscal Year 2015.
Battelle Memorial Institute, Inc. Key Developments
Battelle Memorial Institute Wins $1,575,250 Federal Contract
Jun 20 15
Battelle Memorial Institute won a $1,575,250 federal contract from the U.S. Army Contracting Command, Redstone Arsenal, Alabama, for aircraft accessories and components.
Battelle to Build Suite of Mobile Analytical Labs for U.S. Department of Defense
Jun 8 15
Battelle was awarded a new $25 million contract to build three different mobile lab platforms, called the Common Analytical Laboratory System, over the next three years. The mobile platforms will include a variety of chemical, biological and radiological analytic instruments that will assist service members and first responders in identifying environmental CBR hazards. Since the labs are intended for multiple users, each configuration will support either field confirmation or theater validation; and two will be mounted on vehicles. Work for the project will be conducted at Battelles facilities in Columbus, Ohio; Aberdeen, Maryland; Dublin, Ohio; and Ft. Leonard Wood, Missouri locations.
Battelle and The Feinstein Institute Partner to Create 'Neural Tourniquet'
Jun 4 15
Battelle announced that it has partnered with The Feinstein Institute for Medical Research. Together, the two organizations intend to create a Neural Tourniquet, a technology that will help staunch blood loss through electronic nerve stimulation. The Neural Tourniquet has anticipated applications in planned surgeries, emergency medicine and on the battlefield, and is slated to enter the market in the next three to five years. The Neural Tourniquet represents the latest advancement in bioelectronic medicine, a rapidly developing field that combines molecular medicine, bioengineering and neuroscience to discover and develop nerve-stimulating and sensing technologies to regulate biological processes. Studies conducted during the past decade by the Feinstein Institute demonstrate that a nerve stimulation device can significantly reduce bleeding. Electrical stimulation of neural pathways to the spleen, for as little as 60 seconds, prepares the body for clotting in the event of a wound. The primed coagulation system is able to clot 50% more rapidly and reduce the volume of blood loss by 50%. Battelles strategic partnership with the Feinstein Institute comes at a time of continuing growth in the $4.5 billion market for neurostimulation devices. This market is expected to grow to over $7.8 billion by 2018.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|